ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 112 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $784,000 | +114.8% | 45,497 | +81.0% | 0.00% | – |
| Q4 2021 | $365,000 | +2.5% | 25,133 | +27.1% | 0.00% | – |
| Q3 2021 | $356,000 | -83.2% | 19,773 | -76.5% | 0.00% | -100.0% |
| Q1 2021 | $2,124,000 | +11078.9% | 84,276 | +357.6% | 0.00% | – |
| Q1 2020 | $19,000 | -92.3% | 18,418 | -85.9% | 0.00% | – |
| Q4 2019 | $247,000 | +814.8% | 130,565 | +417.8% | 0.00% | – |
| Q3 2019 | $27,000 | -86.4% | 25,216 | -72.2% | 0.00% | – |
| Q2 2019 | $199,000 | -42.0% | 90,867 | +58.8% | 0.00% | – |
| Q1 2019 | $343,000 | -51.9% | 57,221 | -40.7% | 0.00% | -100.0% |
| Q4 2018 | $713,000 | -52.8% | 96,422 | -7.3% | 0.00% | 0.0% |
| Q3 2018 | $1,510,000 | -32.1% | 104,026 | -6.6% | 0.00% | -50.0% |
| Q2 2018 | $2,224,000 | +181.5% | 111,365 | +146.9% | 0.00% | +100.0% |
| Q1 2018 | $790,000 | +28.0% | 45,111 | +80.2% | 0.00% | 0.0% |
| Q4 2017 | $617,000 | +4.8% | 25,034 | +9.7% | 0.00% | 0.0% |
| Q3 2017 | $589,000 | -23.1% | 22,816 | -19.2% | 0.00% | 0.0% |
| Q2 2017 | $766,000 | -53.6% | 28,243 | -49.0% | 0.00% | -66.7% |
| Q1 2017 | $1,652,000 | +83.6% | 55,397 | +67.0% | 0.00% | +200.0% |
| Q4 2016 | $900,000 | – | 33,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |